| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/30/2013 | US8497350 Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402 |
| 07/30/2013 | US8497248 Antifungal paints and coatings |
| 07/30/2013 | US8497241 WNT10-derived peptide and use thereof |
| 07/30/2013 | US8496942 Therapeutic peptides and uses thereof |
| 07/30/2013 | CA2525476C Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 07/30/2013 | CA2479764C Hemiasterlin derivatives and uses thereof |
| 07/30/2013 | CA2430893C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 07/25/2013 | WO2013110069A1 Glutamic acid-stabilized insulin analogues |
| 07/25/2013 | WO2013108780A1 AMYLOID β-PROTEIN-SPECIFIC PRODUCTION-INHIBITING POLYPEPTIDE |
| 07/25/2013 | WO2013106909A1 Novel peptides and methods and uses thereof for preventing retinal disorders |
| 07/25/2013 | US20130190255 Novel biologically active peptides and their new uses |
| 07/25/2013 | US20130190247 Peptide antagonists of zonulin and methods for use of the same |
| 07/25/2013 | US20130190241 Novel biologically active peptides and their new uses |
| 07/25/2013 | US20130190240 Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 07/25/2013 | US20130190238 Treatments for Gastrointestinal Disorders |
| 07/25/2013 | US20130190228 Novel antiviral peptides against influenza virus |
| 07/25/2013 | US20130190223 Nonimmunosuppressive cyclosporine analogue molecules |
| 07/25/2013 | US20130189784 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo |
| 07/25/2013 | US20130189363 Beta-hairpin peptidomimetics |
| 07/25/2013 | US20130189294 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 07/25/2013 | US20130189291 Peptide Vaccines For Cancers Expressing Tumor-Associated Antigens |
| 07/25/2013 | US20130189268 Colon and pancreas cancer specific antigens and antibodies |
| 07/25/2013 | DE102004038134B4 Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung Multivalent chelators for modifying and organizing of target molecules, processes for their preparation and their use |
| 07/24/2013 | EP2617730A1 Lung cancer identification marker |
| 07/24/2013 | EP2617431A2 Polypeptide inhibitors of HSP27 kinase and uses therefor |
| 07/24/2013 | EP2616480A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 07/24/2013 | EP2616478A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN103221419A Lung cancer identification marker |
| 07/24/2013 | CN103214560A Polypeptide used for preparing bovine foot and mouth disease type O peptide vaccine, and preparation method and application thereof |
| 07/24/2013 | CN103214558A Antimicrobial polypeptides |
| 07/24/2013 | CN103214557A Ezrin antigenic determinant polypeptide, preparation method of phosphorylated Thr566 antibody thereof and kit prepared from the antibody |
| 07/24/2013 | CN103214556A Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MAT1 (Metastasis Associated Gene1) and application thereof |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214554A Mucosal immunoadjuvant inducing Th1 immune response, and application thereof |
| 07/24/2013 | CN103212077A Application of Erbin inhibitor in preparation of antitumor drug |
| 07/24/2013 | CN102229646B Amino acid sequence of bone marrow mesenchymal stem cell affinity peptide, screening method and application |
| 07/24/2013 | CN102153629B Short peptide and application thereof |
| 07/24/2013 | CN101928458B Preparation method of multifunctional nanometer composite particle constructed by modified polymine |
| 07/24/2013 | CN101899092B Novel peptide-link base-conjugate and solid phase synthesis method thereof |
| 07/23/2013 | US8492520 Binding epitopes for G250 antibody |
| 07/23/2013 | US8492518 Mucin hypersecretion inhibitors and methods of use |
| 07/23/2013 | US8492347 Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus |
| 07/23/2013 | US8492345 Cyclic peptide antitumor agents |
| 07/23/2013 | US8492341 Amyloid-β binding peptides |
| 07/23/2013 | US8491910 Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy |
| 07/23/2013 | CA2720332C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 07/18/2013 | WO2013106819A2 Zinc-responsive peptides, and methods of use thereof |
| 07/18/2013 | WO2013106437A1 Apj receptor compounds |
| 07/18/2013 | WO2013105089A2 Anti-inflammatory peptides and use thereof |
| 07/18/2013 | WO2013104728A1 Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
| 07/18/2013 | WO2013104576A1 Cyclopeptide fermentation at increased metal ion concentration |
| 07/18/2013 | WO2013056054A3 Peptide inhibitors of bace1 |
| 07/18/2013 | WO2012159187A3 Denv-derived peptides and methods for the inhibition of the flavivirus replication |
| 07/18/2013 | US20130184629 Skin treatment devices and methods with pre-stressed configurations |
| 07/18/2013 | US20130184433 Method for isolating a cyclohexapeptide |
| 07/18/2013 | US20130184220 Treatment of abnormal or excessive scars |
| 07/18/2013 | US20130184219 Extract and peptides derived from oryza sativa japonica group and uses thereof |
| 07/18/2013 | US20130184202 Peptide Inhibitors and Methods of Use Thereof |
| 07/18/2013 | US20130183267 Cyclosporin analogues for preventing or treating hepatitis c infection |
| 07/18/2013 | US20130183241 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 07/18/2013 | US20130183237 Thrombin inhibitor |
| 07/18/2013 | CA2860864A1 Method for modulating plant root architecture |
| 07/17/2013 | EP2615455A1 Translation and construction of non-standard peptide compound library containing n-methyl amino acids and other non-standard amino acids, and method for searching for active species |
| 07/17/2013 | EP2615105A1 Human-derived cell-permeable peptide bioactive peptide conjugate, and use thereof |
| 07/17/2013 | EP2615104A1 Hepatitis c virus liposome vaccine |
| 07/17/2013 | EP2614146A1 Ttll4 peptides and vaccines containing the same |
| 07/17/2013 | EP2614072A2 Human cytomegalovirus vaccine |
| 07/17/2013 | EP2614059A2 Methods for assaying enzyme activities |
| 07/17/2013 | EP2261380B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 07/17/2013 | CN1568329B Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 07/17/2013 | CN103209989A Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 07/17/2013 | CN103205435A Method for expressing lactoferrin improved peptide LF-6 by using intein escherichia coli |
| 07/17/2013 | CN103204910A Cyclized peptide and preparation method thereof |
| 07/17/2013 | CN103204909A Antihypertensive active peptide VPPIPP (valine-proline-proline-isoleucine-proline-proline) |
| 07/17/2013 | CN103204908A MTA1-derived anti-tumour CTL (cytotoxiclymphocyte) epitope peptide and application thereof |
| 07/17/2013 | CN103204907A Raja porosa cartilage polypeptide angiogenesis inhibitory factor, and preparation method and application thereof |
| 07/17/2013 | CN103204906A Mussel meat protein antioxidative peptide and preparation method thereof |
| 07/17/2013 | CN102391365B A group of new antibiotic peptides, preparation method thereof and use thereof |
| 07/17/2013 | CN102391364B New antibacterial peptides as well as preparation method and application of the same |
| 07/17/2013 | CN101914150B Polypeptide and use thereof in medicament preparation |
| 07/17/2013 | CN101575361B Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
| 07/16/2013 | US8487078 Kinase and phosphatase assays |
| 07/16/2013 | US8487075 Alpha-conotoxin peptides |
| 07/16/2013 | US8487072 Compounds for stimulating P-glycoprotein function and uses thereof |
| 07/16/2013 | US8487047 68Ga generator |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486892 Blood coagulation factor inhibitors |
| 07/16/2013 | US8486373 Intramolecularly-quenched near infrared fluorescent probes |
| 07/16/2013 | CA2496215C Template-fixed peptidomimetics with antibacterial activity |
| 07/16/2013 | CA2490542C Fas peptide mimetics and uses thereof |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2289742C Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 07/11/2013 | WO2013103634A2 N-acylpeptide derivatives and their uses |
| 07/11/2013 | WO2013103614A1 Crlf-2 binding peptides, protocells and viral-like particles useful in the treatment of cancer, including acute lymphoblastic leukemia (all) |
| 07/11/2013 | WO2013102265A1 Compositions and methods for treating multiple sclerosis |
| 07/11/2013 | WO2013102264A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 07/11/2013 | WO2013019445A3 Anti-angiogenic peptides and uses thereof |
| 07/11/2013 | WO2012162534A3 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use |
| 07/11/2013 | US20130178835 Identifying synthetic ligands that bind t-cells from patients having an autoimmune disease |